REGENXBIO Inc.
RGNX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001590877
In the last 90 days, REGENXBIO Inc. insiders filed 1 open-market purchase and 1 sale; 165 institutions reported holding it in 13F filings for Q2 2026, worth $504.6M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in REGENXBIO Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 177
- −5 vs. Q3 2024
- Shares held
- 42.1M
- −1.23M (−2.8%) vs. Q3 2024
- Total value
- $325.2M
- −$129.1M (−28.4%) vs. Q3 2024
- New holders
- 39
- 58 more added
- Sold out
- 44
- 50 more reduced
4 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RGNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 165 | $504.6M |
| Q1 2026 | 178 | $355.1M |
| Q4 2025 | 174 | $593.1M |
| Q3 2025 | 166 | $399.2M |
| Q2 2025 | 159 | $344.9M |
| Q1 2025 | 164 | $298.0M |
| Q4 2024 | 177 | $325.2M |
| Q3 2024 | 186 | $458.1M |
| Q2 2024 | 181 | $511.9M |
| Q1 2024 | 188 | $896.6M |
| Q4 2023 | 171 | $684.3M |
| Q3 2023 | 160 | $610.3M |
| Q2 2023 | 167 | $742.1M |
| Q1 2023 | 175 | $700.0M |
| Q4 2022 | 182 | $808.9M |
| Q3 2022 | 183 | $926.6M |
| Q2 2022 | 166 | $895.7M |
| Q1 2022 | 187 | $1.16B |
| Q4 2021 | 172 | $1.16B |
| Q3 2021 | 183 | $1.40B |
| Q2 2021 | 172 | $1.30B |
| Q1 2021 | 184 | $1.12B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding REGENXBIO Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caxton Associates LP | 0 | $0 | 0.00% | −11,637−100.0% | Sold out |
| Everence Capital Management Inc | 0 | $0 | 0.00% | −11,650−100.0% | Sold out |
| Inceptionr LLC | 0 | $0 | 0.00% | −11,375−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −10,725−100.0% | Sold out |
| Oregon Public Employees Retirement Fund | 0 | $0 | 0.00% | −10,745−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −7,988−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,926−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −3,400−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −3,400−100.0% | Sold out |
| Planned Solutions, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −197−100.0% | Sold out |
| Dynamic Wealth Strategies, LLC | 0 | $0 | 0.00% | −191−100.0% | Sold out |
| Umb Bank N A | 0 | $0 | 0.00% | −153−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −64−100.0% | Sold out |
| Key Financial Inc | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −23−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Mendota Financial Group, LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Ghost Tree Capital, LLC | – | – | – | – | Not filed |
| Raymond James Financial Services Advisors, Inc. | – | – | – | – | Not filed |
| Raymond James & Associates | – | – | – | – | Not filed |
| ClariVest Asset Management LLC | – | – | – | – | Not filed |